Hospital or health organisation · founded 1981
Moffitt Cancer Center
Tampa, United States · moffitt.org
- Citations, last 5 years
- 134.7k
- Works, last 5 years
- 13.7k
- h-index
- 815
- Scientists listed
- 950
- Grants since 2016
- 1 073
Grants received
2018–2023 · cooperative agreement · U01
Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance
Alexander Robertson Allan Anderson · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance
Alexander Robertson Allan Anderson · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Improving Prediction of Chemotherapy-Induced Nausea: Integrating Genes, Behavior, and the Microbiome
Heather S.L. Jim · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R37
Combined radiation acoustics and ultrasound imaging for real-time guidance in radiotherapy
Issam M. El Naqa · Moffitt Cancer Center · funded by National Institutes of Health
2018–2020 · career development · K99
Defining the role of metabolic heterogeneity in melanoma dissemination and therapy escape
Inna Smalley · Moffitt Cancer Center · funded by National Institutes of Health
2018–2025 · research · R01
Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue
Heather S.L. Jim · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue
Heather S.L. Jim · Moffitt Cancer Center · funded by National Institutes of Health
2018–2024 · research · R01
PhI/II Study of CD8-Reduced T Cells for Treatment of MDS or AML IND17305 (12/30/2016)
Hany Elmariah · Moffitt Cancer Center · funded by U.S. Food and Drug Administration
2018–2023 · research · R01
Improving Prediction of Chemotherapy-Induced Nausea: Integrating Genes, Behavior, and the Microbiome
Heather S.L. Jim · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R37
Investigation of NRF2-Dependent Metabolic Liabilities
Gina Marie Denicola · Moffitt Cancer Center · funded by National Institutes of Health
2018–2021 · research · R34
Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation
Christine Vinci · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers
Thomas D Bannister · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
B cell-dependent anti-tumor immunity in ovarian cancer
Jose R Conejo-Garcia · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R37
Investigation of NRF2-Dependent Metabolic Liabilities
Gina Marie Denicola · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R37
Combined radiation acoustics and ultrasound imaging for real-time guidance in radiotherapy
Issam M. El Naqa · Moffitt Cancer Center · funded by National Institutes of Health
2018–2021 · career development · K22
Investigating mechanistic underpinnings and therapeutic potential of selective histone deacetylase and bromodomain inhibition for the treatment of non-small cell lung cancer
Dennis O Adeegbe · Moffitt Cancer Center · funded by National Institutes of Health
2018–2019 · contract · N01
CELL MANUFACTURING AND PROCESS DEVELOPMENT SVCS.: PCT0003-01: CD4+ CM T CELL EXPANSION USE WITH ALLOHCT
Linda Kelley · Moffitt Cancer Center · funded by National Institutes of Health
2018–2024 · cooperative agreement · U24
A Federated Galaxy for user-friendly large-scale cancer genomics research
Jeremy Goecks · Moffitt Cancer Center · funded by National Institutes of Health
2018–2025 · research · R01
Improving Prediction of Chemotherapy-Induced Nausea: Integrating Genes, Behavior, and the Microbiome
Heather S.L. Jim · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance
Alexander Robertson Allan Anderson · Moffitt Cancer Center · funded by National Institutes of Health
2018–2020 · career development · K99
Defining the role of metabolic heterogeneity in melanoma dissemination and therapy escape
Inna Smalley · Moffitt Cancer Center · funded by National Institutes of Health
2018–2021 · research · R21
Autohistomagnetic Isolation of Tumor-reactive T-cells
Adam William Mailloux · Moffitt Cancer Center · funded by National Institutes of Health
2018–2020 · research · R03
An ESC-GEMM platform for rapid melanoma mouse modeling
Florian Karreth · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
PhI/II Study of CD8-Reduced T Cells for Treatment of MDS or AML IND17305 (12/30/2016)
Hany Elmariah · Moffitt Cancer Center · funded by U.S. Food and Drug Administration
2018–2023 · cooperative agreement · U01
B cell-dependent anti-tumor immunity in ovarian cancer
Jose R Conejo-Garcia · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R37
Combined radiation acoustics and ultrasound imaging for real-time guidance in radiotherapy
Issam M. El Naqa · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue
Heather S.L. Jim · Moffitt Cancer Center · funded by National Institutes of Health
2018–2021 · career development · K22
Investigating mechanistic underpinnings and therapeutic potential of selective histone deacetylase and bromodomain inhibition for the treatment of non-small cell lung cancer
Dennis O Adeegbe · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance
Alexander Robertson Allan Anderson · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
B cell-dependent anti-tumor immunity in ovarian cancer
Jose R Conejo-Garcia · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer
John L. Cleveland · Moffitt Cancer Center · funded by National Institutes of Health
2017–2021 · research · R00
The Role of Inflammation in the Racial Disparities in Ovarian Cancer Survival
Lauren Cole Peres · Moffitt Cancer Center · funded by National Institutes of Health
2017–2019 · research · R01
Imaging Habitats in Sarcoma
Robert J. Gillies · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R00
A clone's genomic stability as biomarker of its DNA-damage resilience
Noemi Andor · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Targeting bidirectional signaling in lung stroma and cancer cells
Eric B. Haura · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · award
Biomarkers predictive of tumor location in African American men with PCa
Kosj Yamoah · Moffitt Cancer Center · funded by American Cancer Society
2017–2023 · research · R01
Cell free nucleic acid-based biomarkers in advanced prostate cancer
Manish Kohli · Moffitt Cancer Center · funded by National Institutes of Health
2017–2019 · research · R21
Sequence variation in mtDNA and extreme survival in glioblastoma
Kathleen M. Egan · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Augmenting T cell trafficking and functionality through novel combinations of epigenetic agents and PD-1 blockade
Amer Aziz Beg · Moffitt Cancer Center · funded by National Institutes of Health
2017–2022 · research · R01
Investigation of Oral HPV Infection Natural History and Biomarkers of Persistent Infection: The HIM Study
Anna R. Giuliano · Moffitt Cancer Center · funded by National Institutes of Health